These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1102983)

  • 1. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(24):1236-40. PubMed ID: 1102983
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correction of thrombophilia].
    Caruzzo C; Marcolongo M; Arpino E; Di Summa M
    Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
    [No Abstract]   [Full Text] [Related]  

  • 5. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents: a review.
    Gantmacher ML
    J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet suppressive therapy.
    Turpie AG; Hirsh J
    Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic agents in coronary artery disease.
    Resnekov L; Chediak J; Hirsh J; Lewis D
    Chest; 1986 Feb; 89(2 Suppl):54S-67S. PubMed ID: 3510831
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 16. Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
    Fuster V; Chesebro JH
    Mayo Clin Proc; 1981 Apr; 56(4):265-73 concl. PubMed ID: 7012464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents in coronary disease: are they of prophylactic value?
    Verstraete M
    Drugs; 1978 Jun; 15(6):464-71. PubMed ID: 657992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K
    Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 20. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.